Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for life-threatening severe medical conditions, mainly for children. BMRN is a #3 ...

The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including BioMarin Pharmaceutical (NASDAQ:BMRN) and its ...

But its multipronged assault on California has now begun in earnest. By Shawn Hubler In the annals of ill will between California and the Trump administration, Thursday may have been a record-breaker.

In this article, we are going to look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against other biotech stocks. The biotechnology sector is gaining new momentum with better market ...

California has officially hit a major milestone in its electric vehicle transition: the state now has 48% more EV chargers than gasoline pumps. According to the California Energy Commission, there ...

In this article, we are going to look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against other biotech stocks. The biotechnology sector is gaining new momentum with better market ...

BioMarin Pharma has decided not to divest its haemophilia A gene therapy Roctavian, which has struggled to build much traction in the market, but is reining back its ambitions for the business.